Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04118348 · ClinicalTrials.gov registry record · NA

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

A NA study of Hypercholesterolemia and Hypercholesterolemia, Familial, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
13,340
Enrollment target
1
Study location

NCT04118348 is a NA study of Hypercholesterolemia and Hypercholesterolemia, Familial that has completed, run by Geisinger Clinic. The registered enrollment target is 13,340 participants, above the 602-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (2116% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04118348, a NA study of Hypercholesterolemia and Hypercholesterolemia, Familial, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
13,340 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinations of alerts on provider prescribing behavior and patient uptake of screening.

Interventions

  • BEHAVIORAL Best Practice Alert
  • BEHAVIORAL Health Maintenance Topic

Study Locations (1)

Pennsylvania

  • Geisinger Health System - Danville

Trial Details

FieldValue
Enrollment Target 13,340 participants
Start Date 2019-10-10
Est. Completion 2020-10-11
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT04118348

The ClinicalTrials.gov registry entry for NCT04118348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13,340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 602-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (2116% higher). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 2 interventions - of which Best Practice Alert is the first listed.

NCT04118348 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04118348 about?

NCT04118348 is a clinical study titled "Evaluating the Efficacy of Pediatric Lipid Screening Alerts". The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinatio...

What is the current status of trial NCT04118348?

This trial is currently completed. It is a NA study. The enrollment target is 13,340 participants. The study started on 2019-10-10. Estimated completion is 2020-10-11.

What conditions does trial NCT04118348 study?

This clinical trial studies the following conditions: Hypercholesterolemia, Hypercholesterolemia, Familial, Hypercholesteremia in Children, Hyperlipidemia in Children.

What interventions are being tested in trial NCT04118348?

The interventions under investigation include: Best Practice Alert (BEHAVIORAL), Health Maintenance Topic (BEHAVIORAL).

Who is sponsoring clinical trial NCT04118348?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04118348 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypercholesterolemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.